MARATTO

article

Diagnosis of Malignant Lymphoma Cancer Using Hybrid Optimized Techniques Based on Dense Neural Networks

Abstract

Lymphoma diagnosis, particularly distinguishing between subtypes, is critical for effective treatment but remains challenging due to the subtle morphological differences in histopathological images. This study presents a novel hybrid deep learning framework that combines DenseNet201 for feature extraction with a Dense Neural Network (DNN) for classification, optimized using the Harris Hawks Optimization (HHO) algorithm. The model was trained on a dataset of 15,000 biopsy images, spanning three lymphoma subtypes: Chronic Lymphocytic Leukemia (CLL), Follicular Lymphoma (FL), and Mantle Cell Lymphoma (MCL). Our approach achieved a testing accuracy of 99.33%, demonstrating significant improvements in both accuracy and model interpretability. Comprehensive evaluation using precision, recall, F1-score, and ROC-AUC underscores the model's robustness and potential for clinical adoption. This framework offers a scalable solution for improving diagnostic accuracy and efficiency in oncology.

Research topics

  • AI in cancer detection

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1109/icca62237.2024.10927917

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.